Acid-induced aggregation propensity of nivolumab is dependent on the Fc

Nivolumab, an anti-programmed death (PD)1 IgG(4) antibody, has shown notable success as a cancer treatment. Here, we report that nivolumab was susceptible to aggregation during manufacturing, particularly in routine purification steps. Our experimental results showed that exposure to low pH caused a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:MAbs
Main Authors: Liu, Boning, Guo, Huaizu, Xu, Jin, Qin, Ting, Xu, Lu, Zhang, Junjie, Guo, Qingcheng, Zhang, Dapeng, Qian, Weizhu, Li, Bohua, Dai, Jianxin, Hou, Sheng, Guo, Yajun, Wang, Hao
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2016
Assuntos:
Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4968106/
https://ncbi.nlm.nih.gov/pubmed/27310175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2016.1197443
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados